Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...

Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI).

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin delivery system, according to an industry press release.

The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

The FDA is currently reviewing the compatibility of the Simplera sensor with the MiniMed Go system.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...

The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...

News and commentary from the endocrinology world ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

Caloria is particularly relevant for individuals navigating GLP-1 medications, PCOS, perimenopause and menopause, and other metabolic or hormonal transitions--populations that are often underserved by ...

Delaware Attorney General Kathy Jennings is suing several drug manufacturers and pharmacy benefit managers for reported ...